Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-11-20Clinical Trial Update: Low Vision Depression Prevention Trial for Age Related Macular Degeneration [Phase 3]
Phase 3 trial evaluating prevention of depression in age-related macular degeneration has completed, with results posted in 2014.
-
FDA approval · 2014-11-20FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Epic Pharma LLC)
FDA approved a supplemental application for BUPROPION HYDROCHLORIDE from Epic Pharma LLC under an ANDA.
-
FDA approval · 2014-11-20FDA Approved: BUPROPION HYDROCHLORIDE SR — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Bupropion hydrochloride sustained-release (Bupropion HCl SR) from Actavis Pharma, Inc. under the…
-
CLINICAL_TRIALS trial_result · 2014-11-19Clinical Trial Update: Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder [Phase 3]
Phase 3 trial evaluating SPD489 in combination with an antidepressant for adults with major depressive disorder has completed with posted re…
-
CLINICAL_TRIALS trial_result · 2014-11-19Clinical Trial Update: Primary Prevention of Major Depression Based on the Level and Profile of Risk of Primary Care Attenders: Cluster, Controlled, Randomised Trial [NA]
This clinical trial evaluated primary prevention of major depression in primary care using risk-based profiling in a cluster-randomized desi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-11-19Clinical Trial Update: Pain, Sexual Dysfunction, and Depression in Hemodialysis Patients [NA]
This entry notes the completion and posting of results for a clinical trial in patients undergoing hemodialysis, focusing on pain, sexual dy…
-
CLINICAL_TRIALS trial_result · 2014-11-17Clinical Trial Update: Community Partners in Care is a Research Project Funded by the National Institutes of Health [NA]
A completed NIH-funded study (Community Partners in Care) related to depression and information dissemination; results posted in 2014.
-
FDA approval · 2014-11-17FDA Approved: IMIPRAMINE HYDROCHLORIDE — Supplemental Application (Oxford Pharmaceuticals, LLC)
The FDA approved a supplemental application for imipramine hydrochloride (Oxford Pharmaceuticals, LLC).
-
FDA approval · 2014-11-17FDA Approved: VENLAFAXINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approval of a supplemental application for Venlafaxine from Sun Pharmaceutical Industries, confirming regulatory action on this generic …
-
CLINICAL_TRIALS research · 2014-11-13Clinical Trial Update: Retrospective Observational Study DIANA Study
DIANA, a retrospective observational study sponsored by AstraZeneca investigating major depressive disorder, has completed. This update note…
-
CLINICAL_TRIALS trial_result · 2014-11-11Clinical Trial Update: Efficacy Study of Vortioxetine (Lu AA21004) for Treatment of Major Depressive Disorder [Phase 3]
This document reports the completion and posting of results for a Phase 3 trial evaluating vortioxetine (Lu AA21004) for major depressive di…
-
CLINICAL_TRIALS trial_result · 2014-11-10Clinical Trial Update: Safety, Tolerability and Pharmacokinetics Study of LY03005 [Phase 1]
A Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of LY03005 in adults with Major depressive disorder has been compl…
-
CLINICAL_TRIALS trial_result · 2014-11-10Clinical Trial Update: Treatment Trial for Psychogenic Nonepileptic Seizures [Phase 4]
A Phase 4 trial evaluating treatment for psychogenic non-epileptic seizures has completed.
-
CLINICAL_TRIALS trial_result · 2014-11-07Clinical Trial Update: Reducing Alcohol Use in Depressed Patients [Phase 2]
Phase 2 clinical trial evaluating reduction of alcohol use in patients with depression has completed; the update does not specify results.
-
CLINICAL_TRIALS trial_result · 2014-11-07Clinical Trial Update: Re-Engineering Systems for the Primary Care Treatment for PTSD [Phase 3]
Phase 3 clinical trial evaluating a primary care–based treatment approach for posttraumatic stress disorder, with the study completed and re…
-
CLINICAL_TRIALS trial_result · 2014-11-07Clinical Trial Update: Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder [Phase 3]
Phase 3 trial evaluating SPD489 in combination with an antidepressant for adults with major depressive disorder has completed with posted re…
-
FDA approval · 2014-11-07FDA Approved: SERTRALINE HYDROCHLORIDE — Original Application (Accord Healthcare, Inc.)
FDA approves Accord Healthcare, Inc.'s generic sertraline hydrochloride under an Original Application (ANDA 202825).
-
FDA label_change · 2014-11-06FDA Approved: QUETIAPINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for quetiapine by Teva Pharmaceuticals USA, Inc., resulting in labeling updates for the product. The…
-
CLINICAL_TRIALS trial_result · 2014-11-05Clinical Trial Update: Coping With Depression in Parkinson's Disease [NA]
A completed clinical trial evaluating coping strategies for depression in Parkinson's disease has posted results in November 2014.
-
FDA approval · 2014-11-04FDA Approved: ESCITALOPRAM — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for escitalopram oxalate (escitalopram) from Sun Pharmaceutical Industries, Inc., approving changes …
-
CLINICAL_TRIALS research · 2014-11-04Clinical Trial Update: Clinical Study of PET/CT and Association With Metabolic Syndrome/Depressive Symptoms in Psoriasis
A clinical study investigates the use of PET/CT and its association with metabolic syndrome and depressive symptoms in patients with psorias…
-
FDA approval · 2014-11-03FDA Approved: CITALOPRAM — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approves Amneal Pharmaceuticals LLC's supplemental application for citalopram under ANDA077289, enabling a revised or expanded generic p…
-
CLINICAL_TRIALS trial_result · 2014-11-03Clinical Trial Update: Traditional African Healing Ceremony in a U.S. Population [NA]
A completed clinical trial evaluating the effects of a Traditional African healing ceremony in a U.S. population with Chronic Fatigue Syndro…
-
FDA approval · 2014-10-31FDA Approved: PAROXETINE — Original Application (Solco Healthcare US, LLC)
FDA approved Solco Healthcare US, LLC's original ANDA for paroxetine hydrochloride hemihydrate (paroxetine), making a generic version of the…
-
FDA approval · 2014-10-30FDA Approved: QUETIAPINE — Supplemental Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare Inc.'s supplemental application for quetiapine, enabling the marketing of a generic quetiapine product. The a…